The vasodilator-stimulated phosphoprotein (VASP) is involved in cGMP- and cAMP-mediated inhibition of agonist-induced platelet aggregation, but is dispensable for smooth muscle function.
about
Presynaptically localized cyclic GMP-dependent protein kinase 1 is a key determinant of spinal synaptic potentiation and pain hypersensitivityFyn-binding protein (Fyb)/SLP-76-associated protein (SLAP), Ena/vasodilator-stimulated phosphoprotein (VASP) proteins and the Arp2/3 complex link T cell receptor (TCR) signaling to the actin cytoskeletonRegulation of human endothelial cell focal adhesion sites and migration by cGMP-dependent protein kinase IActin dynamics in plateletsVASP protects actin filaments from gelsolin: an in vitro study with implications for platelet actin reorganizationsEna/VASP: towards resolving a pointed controversy at the barbed endThe cysteine-rich domain of human ADAM 12 supports cell adhesion through syndecans and triggers signaling events that lead to beta1 integrin-dependent cell spreadingRole of proteins of the Ena/VASP family in actin-based motility of Listeria monocytogenesEmergence of large-scale cell morphology and movement from local actin filament growth dynamicsPhosphorylation of the vasodilator-stimulated phosphoprotein regulates its interaction with actinCharacterization of the interaction between zyxin and members of the Ena/vasodilator-stimulated phosphoprotein family of proteinsIRAG is essential for relaxation of receptor-triggered smooth muscle contraction by cGMP kinaseVasodilator-Stimulated Phosphoprotein (VASP)-dependent and -independent pathways regulate thrombin-induced activation of Rap1b in plateletsVasodilator-stimulated phosphoprotein (VASP) induces actin assembly in dendritic spines to promote their development and potentiate synaptic strength.Primary megakaryocytes reveal a role for transcription factor NF-E2 in integrin alpha IIb beta 3 signalingCritical roles of phosphorylation and actin binding motifs, but not the central proline-rich region, for Ena/vasodilator-stimulated phosphoprotein (VASP) function during cell migration.VASP governs actin dynamics by modulating filament anchoring.Actin polymerization in differentiated vascular smooth muscle cells requires vasodilator-stimulated phosphoprotein.The molecular adapter SLP-76 relays signals from platelet integrin alphaIIbbeta3 to the actin cytoskeleton.The VASP-Spred-Sprouty domain puzzle.Thrombocytopenia and platelet abnormalities in high-density lipoprotein receptor-deficient mice.From membrane to cytoskeleton: enabling a connection.Identification and expression analysis of splice variants of mouse enabled homologue during development and in adult tissues.Signaling to actin dynamics.Rap1b is required for normal platelet function and hemostasis in miceCyclic nucleotides and mitogen-activated protein kinases: regulation of simvastatin in platelet activation.Reversible tumorigenesis induced by deficiency of vasodilator-stimulated phosphoprotein.EVH1 domains: structure, function and interactions.Requirement of a vasodilator-stimulated phosphoprotein family member for cell adhesion, the formation of filopodia, and chemotaxis in dictyostelium.Development and hemocompatibility testing of nitric oxide releasing polymers using a rabbit model of thrombogenicityThe role of the adapter molecule SLP-76 in platelet function.Vasodilator-stimulated phosphoprotein regulates proliferation and growth inhibition by nitric oxide in vascular smooth muscle cells.Gene disruption of Spred-2 causes dwarfism.Targeted disruption of the murine zyxin gene.ADAP-ting TCR signaling to integrins.PDE4D and PDE4B function in distinct subcellular compartments in mouse embryonic fibroblastsVascular Nitric Oxide: Formation and Function.Onion (Allium cepa L.) peel extract has anti-platelet effects in rat plateletsPharmacological actions of a novel NO-independent guanylyl cyclase stimulator, BAY 41-8543: in vitro studiessiRNA for Influenza Therapy.
P2860
Q21563535-431870FC-7328-4001-8C09-DA24671209EBQ22253423-3A753786-3C14-4AA8-947E-DEFD71388A33Q22254250-08F032B6-C23F-4C34-92E6-2433ED510A8DQ24603193-BB9DC8D0-AB0E-4148-A7A6-A0087914E068Q24603305-524A54D2-6F01-43BE-9591-12B21BE19361Q24655039-F5AA10D8-F7E6-4904-A645-2938FC7EEB60Q24669779-39305126-92C1-4FC0-B0AB-380F5412C923Q24685793-6585CB63-2D12-4755-B77C-E786647FB13DQ27334367-DBC8B971-C371-4231-9C28-D3677CA22F1FQ28140147-8469EA1D-C1ED-42C6-8E61-6E7C529FD126Q28143848-23E5B9A5-118F-4998-8A50-F9DD41000F66Q28513707-454F43EF-E7F2-409B-97AF-9D21A6AA538DQ30008862-CB21A8D3-7FAA-46D0-AA28-77263777EF62Q30429783-4A197DDD-8714-42DF-B943-4FC2435F4BF1Q30442042-4AFBBA45-9FAB-497E-B13E-BFAB08FA3F18Q30476018-0811084D-45EC-4F25-A8E9-BB2A3F4335A3Q30478859-CB0AFF8D-2028-4913-A1F1-393A53FC1826Q30493668-ADEDAC0D-69F5-486D-A16C-FBE1A1EAB12AQ31673052-A81254CF-CEAE-4431-A61F-E3BAF1D2AEFAQ33343173-DEB02AED-6F79-4CBD-909E-8F058C6CD005Q33379402-AD712F43-8134-40FD-ACD9-96F2712DF5B9Q33590885-D3266D5A-75A8-43A0-88FE-E3FE946AFAF0Q33610987-5F6727CF-0D62-4E17-802D-447BC37352D4Q33699981-7630D064-2212-4BD9-994E-C28BE2477A62Q33778323-B9F9AA63-0AB5-415B-98FD-8674A9ACCC9CQ33951689-0B99D28B-AF51-4C89-80B1-11D48AC23F87Q33958096-E4FC46E9-79A9-42A1-A74D-E49EB26AA035Q34120295-4755038D-F4D1-425F-A4FC-A8A46A311700Q34155214-2DE089BC-2307-493F-8F5A-AC2B5CDE7E32Q34195335-2504EAF3-9E1D-48E1-B717-5FCF08691EEAQ34405516-5FC661D4-E5A7-475A-96D9-41CB2AC14F8FQ34406700-D499983A-A467-4970-9252-DD4DE4F54B96Q34425218-ECA36836-D184-4904-8008-00BAD7A20468Q34462862-A6DD1865-F392-431B-8018-CCA310CC3DCFQ34594450-53EA12DD-9CC7-476C-B9E7-AA7BB82104C3Q34752486-BA1C28D3-489D-4914-863C-DA3DA0781273Q34973956-FE696316-5270-4D8D-BDEA-27F9EA527D6DQ35002507-14608D23-8D1E-4B25-86EC-9038DA569EDDQ35044042-B1CC3149-473C-47E0-9C26-616AEA20F8C8Q35261103-6365FA03-C0FE-42B0-8915-7E3B9346E178
P2860
The vasodilator-stimulated phosphoprotein (VASP) is involved in cGMP- and cAMP-mediated inhibition of agonist-induced platelet aggregation, but is dispensable for smooth muscle function.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The vasodilator-stimulated pho ...... le for smooth muscle function.
@ast
The vasodilator-stimulated pho ...... le for smooth muscle function.
@en
type
label
The vasodilator-stimulated pho ...... le for smooth muscle function.
@ast
The vasodilator-stimulated pho ...... le for smooth muscle function.
@en
prefLabel
The vasodilator-stimulated pho ...... le for smooth muscle function.
@ast
The vasodilator-stimulated pho ...... le for smooth muscle function.
@en
P2093
P2860
P356
P1433
P1476
The vasodilator-stimulated pho ...... ble for smooth muscle function
@en
P2093
Andersson KE
P2860
P356
10.1093/EMBOJ/18.1.37
P407
P577
1999-01-01T00:00:00Z